Skip to main content
. 2015 Oct 30;80(2):243–249. doi: 10.1097/TA.0000000000000912

Figure 1.

Figure 1

Study design and number of patients in cohorts. AKI was defined as KDIGO AKI stage 2 or 3 for Sapphire and was determined by clinical adjudication for Topaz (based on KDIGO stage 2–3 AKI).